Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of nitrocamptothecin in treating patients who have locally recurrent or metastatic breast cancer.

Key facts

Study ID

NCT00005873

Run by

Astex Pharmaceuticals, Inc.

Starts

1999-09-01

Expected to finish

2004-04-01

Last updated by the study team

2013-12-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• SuperGen, Incorporated — Dublin, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.